PATEL SUJAL M (CEO, President, and Secretary) purchased 0.2% of their position (25K shares) of NAUTILUS BIOTECHNOLOGY, INC. on the open market
Open‑market purchase worth $65.2K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 3/4/2026ACC: 0001378830-26-000003
DirectorOfficer10% Owner· CEO, President, and Secretary
Since Jun 2021
+25K
Net shares
Net buyer
$65.2K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
25K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+25K
Price / share
$2.61
Trade value
$65.24K
% of position
0.2%
3/4/2026
10.34M→10.37M
Total
Net shares
+25K
Net value
$65.24K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/4/2026 | P · Purchase | +25K | $2.61 | $65.24K | 0.2% | 10.34M | 10.37M |
| Total | +25K | $65.24K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned1.81M
Common Stock
IndirectShares owned5.28M
Total
7.09M indirect7.09M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.81M | Indirect |
| Common Stock | 5.28M | Indirect |
| Total | 7.09M | 7.09M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported